Some new updates!!!

[CodelikeC]

I would like to announce that AIC has now added several more important repositories to support the long-term development of Parallel TestNet. These include AIC-Beginners, AIC-Tools-Policy, AIC-Security-Harness, AIC-Localization, AIC-Formal, AIC-Reference-Clients, and AIC-Reusable. The goal of each repo is clear, focusing on easier access for both the community and local users, providing clear development tools, secure testing, and reusability at the kernel level:

• Beginners: focuses on building a community for newcomers without disrupting the legal framework or key project statements.

• Tools Policy: provides useful tools to maintain risk acknowledgment while respecting Vietnamese policy and aiming for global PDI.

• Security Harness: This repository provides a foundation for continuous and campaign-style obfuscation on selected AIC surfaces (Ethical Kernel decision paths, SSI lifecycle, recovery logic, governance evaluation). It does not claim that any component has been "cleaned," reinforced for production, or ready for declaration under the Covenant.

• Localization: A further development from AIC-Beginners, targeting local communities based on multilingual attributes, suitable for Global South.

• Formal: Provides machine-testable models of selected invariants appearing in the Ethical Kernel, governance evaluation, SSI operations, recovery paths, and parallel network isolation.

• Reference Clients: User-oriented, minimal pure-Python/Rust/Go clients.

• Reusable: Toxiproxy/tc-netem/Testcontainers configs + scenario library for Parallel TestNet.

These are necessary additions and could be more widely disseminated to the technical community, administrators, and those interested in secure, transparent, and respectful PDI. Currently, some repositories are still in a mix of private and public states, so we hope to receive support from everyone. AIC is entering the post-Whitepaper era, a significant transition from implementation, principles, and philosophy to a complete experiment. We will continue to update you with the latest information in the coming time. Thank you everyone.